Persistent URL of this record https://hdl.handle.net/1887/113092
In Collections
This item can be found in the following collections:
![Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)
- All authors
- Wick, W.; Gorlia, T.; Bady, P.; Platten, M.; Bent, M.J. van den; Taphoorn, M.J.B.; Steuve, J.; Brandes, A.A.; Hamou, M.F.; Wick, A.; Kosch, M.; Weller, M.; Stupp, R.; Roth, P.; Golfinopoulos, V.; Frenel, J.S.; Campone, M.; Ricard, D.; Marosi, C.; Villa, S.; Weyerbrock, A.; Hopkins, K.; Homicsko, K.; Lhermitte, B.; Pesce, G.; Hegi, M.E.
- Date
- 2016-10-01
- Journal
- Clinical Cancer Research
- Volume
- 22
- Issue
- 19
- Pages
- 4797 - 4806